ClinVar Miner

Submissions for variant NM_001148.6(ANK2):c.8768A>G (p.Gln2923Arg)

gnomAD frequency: 0.00001  dbSNP: rs551454026
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV000631775 SCV000752865 benign Long QT syndrome 2024-12-30 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV001148490 SCV001309389 likely benign Cardiac arrhythmia, ankyrin-B-related 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease.
Genome-Nilou Lab RCV001148490 SCV002525078 benign Cardiac arrhythmia, ankyrin-B-related 2021-12-05 criteria provided, single submitter clinical testing
Ambry Genetics RCV002377358 SCV002685886 benign Cardiovascular phenotype 2022-02-20 criteria provided, single submitter clinical testing This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Fulgent Genetics, Fulgent Genetics RCV001148490 SCV002795495 likely benign Cardiac arrhythmia, ankyrin-B-related 2021-09-14 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV003437339 SCV004148755 likely benign not provided 2024-09-01 criteria provided, single submitter clinical testing ANK2: BP4, BS2
PreventionGenetics, part of Exact Sciences RCV004745513 SCV005348814 likely benign ANK2-related disorder 2024-04-09 no assertion criteria provided clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.